D
Oscar Health, Inc.
OSCR
$18.02
-$0.07-0.39%
D
Sell
3/7/2024Upgraded
Oscar Health, Inc. (OSCR) was upgraded to D- from E+ on 3/7/2024 due to an increase in the valuation index and total return index.
Oscar Health, Inc. (OSCR) was upgraded to D- from E+ on 3/7/2024 due to an increase in the valuation index and total return index.
E
Sell
2/21/2024Downgrade
Oscar Health, Inc. (OSCR) was downgraded to E+ from D- on 2/21/2024 due to a noticeable decline in the growth index and valuation index. EBIT declined 149.77% from -$58.24M to -$145.48M, earnings per share declined from -$0.2931 to -$0.6607, and total revenue declined 1.19% from $1.44B to $1.43B.
Oscar Health, Inc. (OSCR) was downgraded to E+ from D- on 2/21/2024 due to a noticeable decline in the growth index and valuation index. EBIT declined 149.77% from -$58.24M to -$145.48M, earnings per share declined from -$0.2931 to -$0.6607, and total revenue declined 1.19% from $1.44B to $1.43B.
D
Sell
4/21/2023Upgraded
Oscar Health, Inc. (OSCR) was upgraded to D- from E+ on 4/21/2023 due to an increase in the total return index and volatility index.
Oscar Health, Inc. (OSCR) was upgraded to D- from E+ on 4/21/2023 due to an increase in the total return index and volatility index.
E
Sell
3/14/2023Downgrade
Oscar Health, Inc. (OSCR) was downgraded to E+ from D on 3/14/2023 due to a decline in the growth index and solvency index. Debt to equity increased from 0.28 to 0.35, earnings per share declined from -$0.9064 to -$1.0504, and EBIT declined 15.65% from -$192.37M to -$222.48M.
Oscar Health, Inc. (OSCR) was downgraded to E+ from D on 3/14/2023 due to a decline in the growth index and solvency index. Debt to equity increased from 0.28 to 0.35, earnings per share declined from -$0.9064 to -$1.0504, and EBIT declined 15.65% from -$192.37M to -$222.48M.
D
Sell
2/10/2023Upgraded
Oscar Health, Inc. (OSCR) was upgraded to D from E+ on 2/10/2023 due to an increase in the volatility index and total return index.
Oscar Health, Inc. (OSCR) was upgraded to D from E+ on 2/10/2023 due to an increase in the volatility index and total return index.
E
Sell
2/8/2023Downgrade
Oscar Health, Inc. (OSCR) was downgraded to E+ from D- on 2/8/2023 due to a decline in the valuation index.
Oscar Health, Inc. (OSCR) was downgraded to E+ from D- on 2/8/2023 due to a decline in the valuation index.
D
Sell
1/10/2023Downgrade
Oscar Health, Inc. (OSCR) was downgraded to D- from D on 1/10/2023 due to a decline in the volatility index and total return index.
Oscar Health, Inc. (OSCR) was downgraded to D- from D on 1/10/2023 due to a decline in the volatility index and total return index.
D
Sell
12/19/2022Upgraded
Oscar Health, Inc. (OSCR) was upgraded to D from D- on 12/19/2022 due to an increase in the volatility index.
Oscar Health, Inc. (OSCR) was upgraded to D from D- on 12/19/2022 due to an increase in the volatility index.
D
Sell
12/2/2022Downgrade
Oscar Health, Inc. (OSCR) was downgraded to D- from D on 12/2/2022 due to a decline in the volatility index and total return index.
Oscar Health, Inc. (OSCR) was downgraded to D- from D on 12/2/2022 due to a decline in the volatility index and total return index.
D
Sell
11/11/2022Upgraded
Oscar Health, Inc. (OSCR) was upgraded to D from D- on 11/11/2022 due to an increase in the growth index and volatility index.
Oscar Health, Inc. (OSCR) was upgraded to D from D- on 11/11/2022 due to an increase in the growth index and volatility index.
D
Sell
11/10/2022Downgrade
Oscar Health, Inc. (OSCR) was downgraded to D- from D on 11/10/2022 due to a decline in the growth index, volatility index and solvency index. Operating cash flow declined 61.9% from $562.85M to $214.47M, EBIT declined 55.39% from -$68.53M to -$106.49M, and earnings per share declined from -$0.3569 to -$0.5308.
Oscar Health, Inc. (OSCR) was downgraded to D- from D on 11/10/2022 due to a decline in the growth index, volatility index and solvency index. Operating cash flow declined 61.9% from $562.85M to $214.47M, EBIT declined 55.39% from -$68.53M to -$106.49M, and earnings per share declined from -$0.3569 to -$0.5308.
D
Sell
5/16/2022Upgraded
Oscar Health, Inc. (OSCR) was upgraded to D from E+ on 05/16/2022.
Oscar Health, Inc. (OSCR) was upgraded to D from E+ on 05/16/2022.
E
Sell
5/13/2022Downgrade
Oscar Health, Inc. (OSCR) was downgraded to E+ from D on 5/13/2022 due to a decline in the solvency index and growth index. Debt to equity increased from 0.01 to 0.22.
Oscar Health, Inc. (OSCR) was downgraded to E+ from D on 5/13/2022 due to a decline in the solvency index and growth index. Debt to equity increased from 0.01 to 0.22.
D
Sell
5/4/2022Upgraded
Oscar Health, Inc. (OSCR) was upgraded to D from E+ on 5/4/2022 due to an increase in the volatility index.
Oscar Health, Inc. (OSCR) was upgraded to D from E+ on 5/4/2022 due to an increase in the volatility index.
E
Sell
5/1/2022Downgrade
Oscar Health, Inc. (OSCR) was downgraded to E+ from D on 05/01/2022.
Oscar Health, Inc. (OSCR) was downgraded to E+ from D on 05/01/2022.
D
Sell
4/21/2022Upgraded
Oscar Health, Inc. (OSCR) was upgraded to D from E+ on 04/21/2022.
Oscar Health, Inc. (OSCR) was upgraded to D from E+ on 04/21/2022.
E
Sell
4/20/2022Downgrade
Oscar Health, Inc. (OSCR) was downgraded to E+ from D on 04/20/2022.
Oscar Health, Inc. (OSCR) was downgraded to E+ from D on 04/20/2022.
D
Sell
2/28/2022Upgraded
Oscar Health, Inc. (OSCR) was upgraded to D from D- on 2/28/2022 due to a significant increase in the growth index, solvency index and valuation index. Operating cash flow increased 105.85% from -$589.25M to $34.48M, total revenue increased 19.52% from $448.65M to $536.25M, and EBIT increased 7.6% from -$212.94M to -$196.76M.
Oscar Health, Inc. (OSCR) was upgraded to D from D- on 2/28/2022 due to a significant increase in the growth index, solvency index and valuation index. Operating cash flow increased 105.85% from -$589.25M to $34.48M, total revenue increased 19.52% from $448.65M to $536.25M, and EBIT increased 7.6% from -$212.94M to -$196.76M.
D
Sell
12/28/2021Downgrade
Oscar Health, Inc. (OSCR) was downgraded to D- from D on 12/28/2021 due to a decline in the total return index and volatility index.
Oscar Health, Inc. (OSCR) was downgraded to D- from D on 12/28/2021 due to a decline in the total return index and volatility index.
D
Sell
12/6/2021Upgraded
Oscar Health, Inc. (OSCR) was upgraded to D from D- on 12/6/2021 due to an increase in the volatility index and valuation index.
Oscar Health, Inc. (OSCR) was upgraded to D from D- on 12/6/2021 due to an increase in the volatility index and valuation index.
D
Sell
11/16/2021Downgrade
Oscar Health, Inc. (OSCR) was downgraded to D- from D on 11/16/2021 due to a major decline in the growth index, efficiency index and total return index. Operating cash flow declined 1,164.84% from $55.34M to -$589.25M, EBIT declined 194.73% from -$72.25M to -$212.94M, and net income declined 191.16% from -$73.07M to -$212.75M.
Oscar Health, Inc. (OSCR) was downgraded to D- from D on 11/16/2021 due to a major decline in the growth index, efficiency index and total return index. Operating cash flow declined 1,164.84% from $55.34M to -$589.25M, EBIT declined 194.73% from -$72.25M to -$212.94M, and net income declined 191.16% from -$73.07M to -$212.75M.
D
Sell
8/18/2021None
Oscar Health, Inc. (OSCR) was downgraded to D from U on 08/18/2021.
Oscar Health, Inc. (OSCR) was downgraded to D from U on 08/18/2021.
NYSE
05/03/2024 4:00PM Eastern
Quotes delayed
